Skip to main content

Table 1 Main clinical and conventional echocardiographic characteristics of the four study groups

From: Clinical implication of disturbed left atrial phasic functions in the heterogeneous population associated with hypertension or atrial fibrillation

Variable

Controls

(n = 28)

Isolated HTN group

(n = 25)

Lone AF group

(n = 24)

HTN and PAF group

(n = 28)

P

Age, years

56.7 ± 9.3

58.3 ± 8.9

53.8 ± 6.7

60.9 ± 6.6

0.386

Female gender, n (%)

13 (46%)

14 (56%)

13 (54%)

8 (29%)

0.166

Height, cm

166.8 ± 8.1

163.8 ± 6.7

170.0 ± 10.1

165.8 ± 7.4

0.061

Weight, kg

62.6 ± 9.6

62.2 ± 10.7

65.8 ± 10.0

65.7 ± 9.4

0.403

Body mass index, kg/m2

22.29 ± 2.53

23.06 ± 2.79

22.26 ± 2.36

23.83 ± 2.42

0.079

Body surface area, m2

1.70 ± 0.16

1.67 ± 0.17

1.77 ± 0.17

1.73 ± 0.15

0.180

Heart rate, beats/min

73.0 ± 7.7

70.5 ± 7.3

67.4 ± 11.5

68.5 ± 6.5

0.108

SBP, mm Hg

114.1 ± 6.9

159.0 ± 13.5*

113.9 ± 6.9

162.1 ± 8.8*

0.000

DBP, mm Hg

83.2 ± 3.7

100.4 ± 5.6*

80.6 ± 4.7

99.6 ± 7.3*

0.000

History of HTN, years

–

8.0 ± 4.6

–

11.9 ± 4.5#

0.003

History of AF, years

–

–

4.5 ± 3.9

5.4 ± 4.5

0.468

Current smoker, n (%)

5 (18%)

10 (36%)

–

9 (32%)

0.198

Current drinker, n (%)

4 (7%)

5 (28%)

–

8 (46%)

0.418

Medications, n (%)

 ACEI or ARB

–

13 (52%)

–

16 (57%)

0.707

 β-blockers

–

7 (28%)

–

6 (21%)

0.579

 Calcium antagonists

–

6 (24%)

–

6 (21%)

0.823

 Antiplatelet

–

–

8 (33%)

11 (39%)

0.657

 Anticoagulant agent

–

–

11 (46%)

15 (54%)

0.578

 Antiarrhythmic drug

–

–

12 (50%)

17 (61%)

0.438

 Diuretics

–

5 (20%)

3 (13%)

8 (46%)

0.360

 Statins

–

8 (32%)

4 (17%)

11 (39%)

0198

Mild mitral regurgitation, n (%)

–

4 (16%)

7 (29%)

10 (36%)

0.266

Mild aortic regurgitation, n (%)

–

8 (32%)

3 (13%)

11 (39%)

0.093

LVEF, %

64.16 ± 2.79

63.65 ± 4.12

63.54 ± 4.13

63.86 ± 3.29

0.936

LVMI, g/m2

81.44 ± 7.26

108.52 ± 12.26*

77.41 ± 6.87

109.60 ± 19.21*

0.000

E/e’ ratio

8.24 ± 1.88

10.51 ± 2.85*

9.74 ± 2.76

10.96 ± 8.05*

0.007

LAVI, mL/m2

25.73 ± 5.66

31.93 ± 8.62*

27.60 ± 8.47

33.16 ± 10.08*

0.007

  1. ACE Angiotensin converting enzyme, AF Atrial fibrillation, ARB Angiotensin receptor blocker, DBP Diastolic blood pressure, HTN Hypertension, LAVI Left atrial volume index, LVEF Left ventricular ejection fraction, LVMI Left ventricular mass index, PAF Paroxysmal atrial fibrillation, SBP Systolic blood pressure
  2. *P < 0.05 vs. controls, #P < 0.05 vs. isolated HTN group
  3. Data are expressed as mean ± SD or as number (percentage)